WORCESTER, Mass., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it will present clinical data at the 20th World Diabetes Congress (www.worlddiabetescongress.org) of the International Diabetes Federation (www.idf.org) being held in Montreal, Canada, 18-22 October, 2009.
